You are here: Provider Connection Home » All Articles » Healthcare » The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients

The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients

Published on: July 17, 2020
Last updated: October 12, 2021

Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.

Link: https://care.choc.org/the-forefront-of-car-t-cell-immunotherapy-research-for-high-risk-pediatric-leukemia-patients/